Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (411-420 of 496) with videos related to

Pageof 50
Sort By:
Clinical and Experimental Rheumatology|October 18, 2016
MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritisChristian H Roux, Violaine Foltz, Emmanuel Maheu, et al.
Joint Bone Spine|January 1, 2024
Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception CohortMaxime Dougados, Chris Serrand, Sandrine Alonso, et al.
Joint Bone Spine|May 31, 2020
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020Christophe Richez, René-Marc Flipo, Francis Berenbaum, et al.
Joint Bone Spine|November 18, 2011
Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide seriesÉric Toussirot, Éric Houvenagel, Vincent Goëb, et al.
Rheumatology (Oxford, England)|April 22, 2026
Bacterial translocation and intestinal permeability in early axial spondyloarthritis association with 5-year outcomes: insights from the DESIR cohortFrank Verhoeven, Olivier Fakih, Sophie Hecquet, et al.
Plos One|May 22, 2015
Online training on skin cancer diagnosis in rheumatologists: results from a nationwide randomized web-based surveyManuelle Viguier, Stéphanie Rist, François Aubin, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|January 25, 2021
Christophe Richez, René-Marc Flipo, Francis Berenbaum, et al.
The Journal of Rheumatology|February 3, 2015
Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patientYves-Marie Pers, Marie Godfrin-Valnet, Joseph Lambert, et al.
Arthritis Research & Therapy|October 24, 2009
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patientsMichel de Bandt, Bruno Fautrel, Jean Francis Maillefert, et al.
Arthritis and Rheumatism|April 1, 2009
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferencesBruno Fautrel, Francis Guillemin, Olivier Meyer, et al.
Pageof 50

Showing results (411-420 of 496) with videos related to

Sort By:
Pageof 50
Clinical and Experimental Rheumatology|October 18, 2016
MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritisChristian H Roux, Violaine Foltz, Emmanuel Maheu, et al.
Joint Bone Spine|January 1, 2024
Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception CohortMaxime Dougados, Chris Serrand, Sandrine Alonso, et al.
Joint Bone Spine|May 31, 2020
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020Christophe Richez, René-Marc Flipo, Francis Berenbaum, et al.
Joint Bone Spine|November 18, 2011
Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide seriesÉric Toussirot, Éric Houvenagel, Vincent Goëb, et al.
Rheumatology (Oxford, England)|April 22, 2026
Bacterial translocation and intestinal permeability in early axial spondyloarthritis association with 5-year outcomes: insights from the DESIR cohortFrank Verhoeven, Olivier Fakih, Sophie Hecquet, et al.
Plos One|May 22, 2015
Online training on skin cancer diagnosis in rheumatologists: results from a nationwide randomized web-based surveyManuelle Viguier, Stéphanie Rist, François Aubin, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|January 25, 2021
Christophe Richez, René-Marc Flipo, Francis Berenbaum, et al.
The Journal of Rheumatology|February 3, 2015
Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patientYves-Marie Pers, Marie Godfrin-Valnet, Joseph Lambert, et al.
Arthritis Research & Therapy|October 24, 2009
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patientsMichel de Bandt, Bruno Fautrel, Jean Francis Maillefert, et al.
Arthritis and Rheumatism|April 1, 2009
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferencesBruno Fautrel, Francis Guillemin, Olivier Meyer, et al.
Pageof 50